Related Experiment Videos

More is not always better: a case for low-dose leucovorin

M M Borner, O Sartor

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|February 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Next generation radiotheranostics promoting precision medicine.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.

ESMO open·2021

An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer.

ESMO open·2021

Advances in targeted alpha therapy for prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

See all related articles